Clinical trial
A Phase 2a, Open-label, Randomized, Controlled, Multi-center Proof of Concept Study to Assess the Efficacy, Safety, and Tolerability of VS-01 on Top of Standard of Care, Compared to Standard of Care Alone, in Adult Patients With Acute-on-chronic Liver Failure (ACLF)
NCT05900050 is registered in ClinicalTrials.gov with Genfit as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2a, Open-label, Randomized, Controlled, Multi-center Proof of Concept Study to Assess the Efficacy, Safety, and Tolerability of VS-01 on Top of Standard of Care, Compared to Standard of Care Alone, in Adult Patients With Acute-on-chronic Liver Failure (ACLF)
- Lead sponsor
- Genfit
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- July 2, 2023
- Completion date
- October 15, 2025
- Enrollment
- 15 (actual)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.